DePuy execs to testify in hip implant recall trials
Eight executives from Johnson & Johnson's DePuy Orthopaedics division are slated to testify in the personal injury lawsuits filed over its recalled DePuy ASR metal-on-metal hip implant.
Eight former and current executives from Johnson & Johnson's (NYSE:JNJ) DePuy Orthopaedics subsidiary are being called to testify in the multi-district litigation over the recalled DePuy ASR metal-on-metal hip implant.
Warsaw, Ind.-based DePuy Orthopedics pulled its ASR XL acetabular and ASR hip resurfacing systems off the market in August 2010, after receiving reports that a higher-than-normal number of patients required surgeries to correct or remove defective implants.
Prompted by data showing "a 5-year revision rate of approximately 12% for the ASR Hip Resurfacing System and approximately 13% for the ASR XL Acetabular System", according to DePuy, the recall affected more than 96,000 patients.